2020
T-cell and NK-cell lymphomas in the lung
Pan Z, Xu ML. T-cell and NK-cell lymphomas in the lung. Seminars In Diagnostic Pathology 2020, 37: 273-282. PMID: 32448591, DOI: 10.1053/j.semdp.2020.04.003.Peer-Reviewed Original ResearchConceptsT-cell lymphomaWorld Health Organization classificationNK-cell lymphomasAdequate antibiotic therapyTypical radiologic featuresPrinciples of treatmentDifferent histologic typesPrecise pathologic diagnosisHilar adenopathyEmpirical antibioticsSystemic lymphomaWedge biopsyAntibiotic therapyLymphomas accountRadiologic featuresRadiologic findingsBronchoscopic examinationHistologic typePleural effusionClinical symptomsRecurrent infectionsCystic changesOrganization classificationPathologic diagnosisPulmonary opacities
2019
Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis
Xu ML, Gabali A, Hsi ED, Fedoriw Y, Vij K, Salama ME, Ramchandren R, O’Malley D, Wick MR, Battistella M, Gru AA. Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis. The American Journal Of Surgical Pathology 2019, 44: e1-e14. PMID: 31567279, DOI: 10.1097/pas.0000000000001368.Peer-Reviewed Original Research
2016
Lymphoma Microenvironment and Immunotherapy
Xu ML, Fedoriw Y. Lymphoma Microenvironment and Immunotherapy. Surgical Pathology Clinics 2016, 9: 93-100. PMID: 26940270, DOI: 10.1016/j.path.2015.10.001.Peer-Reviewed Original ResearchMeSH KeywordsHumansImmune EvasionImmunologic SurveillanceImmunotherapyLymphomaTumor Microenvironment
2013
Venting the Spleen
Varughese N, Duong A, Emre S, Xu M, Lee AI. Venting the Spleen. New England Journal Of Medicine 2013, 369: 1357-1363. PMID: 24088096, DOI: 10.1056/nejmcps1210943.Peer-Reviewed Original ResearchPD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Chen BJ, Chapuy B, Ouyang J, Sun HH, Roemer MG, Xu ML, Yu H, Fletcher CD, Freeman GJ, Shipp MA, Rodig SJ. PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies. Clinical Cancer Research 2013, 19: 3462-3473. PMID: 23674495, PMCID: PMC4102335, DOI: 10.1158/1078-0432.ccr-13-0855.Peer-Reviewed Original ResearchConceptsDiffuse large B-cell lymphomaAggressive B-cell lymphomasB-cell lymphomaPosttransplant lymphoproliferative disorderClassical Hodgkin lymphomaLarge B-cell lymphomaPD-L1Hodgkin's lymphomaT-cell/histiocyte-rich B-cell lymphomaExtranodal NK/T-cell lymphomaTissue biopsiesEBV-positive posttransplant lymphoproliferative disordersHistiocyte-rich B-cell lymphomaPD-1/PD-L1 pathwayNK/T-cell lymphomaPD-1/PD-L1Primary mediastinal large B-cell lymphomaNodular lymphocyte predominant Hodgkin lymphomaMixed cellularity classical Hodgkin lymphomaMediastinal large B-cell lymphomaCell death ligand 1Lymphocyte predominant Hodgkin lymphomaPD-L1 protein expressionPD-L1 expressionPD-L1 pathway